RALEIGH, N.C., May 16, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that the head of our Early Development Services (EDS) group will speak at the 5th Annual Exploratory Clinical Development World conference being held in London, United Kingdom from 18-20 May 2011. PRA will also host an exhibit at booth #1.
Dr. Willem Jan Drijfhout, Senior Vice President of PRA's EDS group, will present opening remarks at 8:20am for day one of the event on 18 May. At 9:00am that morning, Dr. Drijfhout will present "Data-Driven Decision Making in Drug Development," which will highlight methods for identifying key information needed to reach objective decisions efficiently in early phase clinical trials.
As senior vice president of EDS, Dr. Drijfhout is responsible for leading all early phase and bioanalytical work for PRA. He has nearly 20 years of experience in drug development as well as 10 years in Phase I clinical trials, and holds a Ph.D. in pharmacy.
PRA EDS is an international group helping pharmaceutical and biotechnology customers in our Phase I development programs. Through our harmonized clinical and laboratory facilities in The Netherlands, the United States and Central and Eastern Europe, PRA offers over 275 beds for patient and subject studies worldwide. Our global teams can meet the needs of any Phase I study design required in the industry today.
About PRA
PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 40 global offices.
PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT— enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.
To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International
Advertisement
Dr. Willem Jan Drijfhout, Senior Vice President of PRA's EDS group, will present opening remarks at 8:20am for day one of the event on 18 May. At 9:00am that morning, Dr. Drijfhout will present "Data-Driven Decision Making in Drug Development," which will highlight methods for identifying key information needed to reach objective decisions efficiently in early phase clinical trials.
Advertisement
As senior vice president of EDS, Dr. Drijfhout is responsible for leading all early phase and bioanalytical work for PRA. He has nearly 20 years of experience in drug development as well as 10 years in Phase I clinical trials, and holds a Ph.D. in pharmacy.
PRA EDS is an international group helping pharmaceutical and biotechnology customers in our Phase I development programs. Through our harmonized clinical and laboratory facilities in The Netherlands, the United States and Central and Eastern Europe, PRA offers over 275 beds for patient and subject studies worldwide. Our global teams can meet the needs of any Phase I study design required in the industry today.
About PRA
PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 40 global offices.
PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT— enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.
To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.
SOURCE PRA International
